Updates in the Use of Biologic Agents to Treat Eosinophilic Asthma
May 9, 2024
Via Zoom
Target Audience
All pharmacists
Learning Objectives
At the completion of this activity, the participant will be able to:
Define eosinophilic asthma and what characteristics differentiate it from other forms of
asthma.
Recall the pathophysiology of eosinophilic asthma and why it necessitates a different
management strategy.
List current management strategies for eosinophilic asthma.
Identify recommended immunomodulatory agents available to treat eosinophilic
asthma
Hospital
NY
12866
United States
Name: Amrita Bose, PharmD, BPS - Dr. Amrita Bose is from New York City. She earned her Doctor of Pharmacy degree from Long Island University (Brooklyn, NY). She is currently a PGY-1 Pharmacy Resident at The Mount Sinai Hospital (Manhattan, New York
ACPE UAN #
0042-0000-24-032-L01-P | ||||||||||||
Available Credit
- 1.00 ACPEThe Arnold & Marie Schwartz College of Pharmacy and Health Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.